Oxybutynin Chloride Tablet
Product Images NDC 71610-394

5 FDA label images from Aphena Pharma Solutions - Tennessee, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 71610-394). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Bottle Label 5 mg (71610 0394 53)

Bottle Label 5 mg (71610 0394 53)
Label for Oxybutynin Chloride USP 5 mg oral tablets, 60 count, labeled with NDC 71610-0394-53. Manufactured by Tulex Pharmaceuticals Inc., packaged by Aphena Pharma Solutions - Tennessee, LLC. Storage instructions specify 20-25 degrees Celsius, protect from light in a tight-resistant container, keep out of reach of children. Label includes barcode and QR code.*
FDA Label Image

Aphena Pharma Solutions (TN)

Aphena Pharma Solutions (TN)
FDA Label Image

This Is An Image Of The Structural Formula For Oxybutynin Chloride. (Oxybutynin Chloride Tablets 1)

This Is An Image Of The Structural Formula For Oxybutynin Chloride. (Oxybutynin Chloride Tablets 1)
Chemical structure diagram of oxybutynin chloride showing its molecular components including aromatic rings, ester linkages, and the hydrochloride group.*
FDA Label Image

Figure 1. Mean R-oxybutynin Plasma Concentrations Following Three Doses Of Oxybutynin Chloride 5 mg Administered Every 8 Hours For 1 Day In 23 Healthy Adult Volunteers (Oxybutynin Chloride Tablets 2)

Figure 1. Mean R-oxybutynin Plasma Concentrations Following Three Doses Of Oxybutynin Chloride 5 mg Administered Every 8 Hours For 1 Day In 23 Healthy Adult Volunteers (Oxybutynin Chloride Tablets 2)
A line graph depicting mean plasma R-oxybutynin concentration (ng/mL) over 24 hours after oral dosing of oxybutynin 5 mg taken three times daily (TID). Concentration peaks occur several times in the 24-hour period, with error bars indicating variability at each time point.*
FDA Label Image

Figure 2.mean Steady-state (±sd) R-oxybutynin Plasma Concentrations Following Administration Of Total Daily Oxybutynin Chloride Tablet Dose Of 7.5 mg To 15 mg (0.22 mg/kg To 0.53 mg/kg) In Children 5 (Oxybutynin Chloride Tablets 3)

Figure 2.mean Steady-state (±sd) R-oxybutynin Plasma Concentrations Following Administration Of Total Daily Oxybutynin Chloride Tablet Dose Of 7.5 mg To 15 mg (0.22 mg/kg To 0.53 mg/kg) In Children 5 (Oxybutynin Chloride Tablets 3)
A line graph depicting the mean R-Oxybutynin plasma concentration (ng/mL) over time (hours). Mean plasma concentration peaks around 1 hour after dosing, then declines steadily, approaching baseline levels by 12 hours.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.